AtriCure - Stock Price History | ATRC

Historical daily share price chart and data for AtriCure since 2020 adjusted for splits. The latest closing stock price for AtriCure as of October 23, 2020 is 37.96.
  • The all-time high AtriCure stock closing price was 51.19 on June 08, 2020.
  • The AtriCure 52-week high stock price is 51.76, which is 36.4% above the current share price.
  • The AtriCure 52-week low stock price is 23.16, which is 39% below the current share price.
  • The average AtriCure stock price for the last 52 weeks is 38.60.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
AtriCure Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 29.1289 30.2500 33.3400 23.8100 32.5100 6.24%
2018 26.1470 18.4700 35.5800 15.0500 30.6000 67.76%
2017 20.3076 19.2000 24.8800 14.9400 18.2400 -6.80%
2016 16.5649 21.1600 21.4700 13.5400 19.5700 -12.79%
2015 21.8535 19.7800 27.9300 17.4000 22.4400 12.42%
2014 17.5247 18.0300 22.1800 13.6400 19.9600 6.85%
2013 10.3316 7.1400 18.9300 7.1400 18.6800 170.72%
2012 8.5684 11.7400 11.9600 5.9100 6.9000 -37.84%
2011 11.4511 10.2500 14.5000 8.5400 11.1000 8.08%
2010 6.7755 5.6500 10.2700 4.5600 10.2700 70.03%
2009 3.2447 2.2000 6.0500 1.0700 6.0400 172.07%
2008 9.7793 13.2400 14.0500 2.0000 2.2200 -83.07%
2007 10.6159 9.1500 13.5900 8.4400 13.1100 46.64%
2006 8.1361 10.7900 11.8000 5.4400 8.9400 -16.06%
2005 13.1674 14.0800 14.9500 10.6500 10.6500 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.720B $0.231B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $193.838B 34.76
Medtronic (MDT) Ireland $150.337B 28.31
Stryker (SYK) United States $84.201B 32.65
Boston Scientific (BSX) United States $52.735B 30.46
Lonza Group Ag (LZAGY) Switzerland $46.915B 0.00
Baxter (BAX) United States $41.233B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.618B 24.58
EssilorLuxottica Societe Anonyme (ESLOY) France $29.595B 0.00
Terumo (TRUMY) Japan $28.421B 36.33
ResMed (RMD) United States $26.492B 38.41
Sunny Optical Technology (SNPTF) China $17.297B 0.00
Bio-Rad Laboratories (BIO) United States $17.185B 77.72
Smith & Nephew SNATS (SNN) United Kingdom $16.848B 0.00
Insulet (PODD) United States $16.101B 681.25
DiaSorin S.p.A (DSRLF) Italy $12.588B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
Quidel (QDEL) United States $10.309B 54.61
GN STORE NORD (GNNDY) Denmark $9.996B 50.95
William Demant Holdings (WILYY) Denmark $8.193B 0.00
Canopy Growth (CGC) Canada $7.547B 0.00
Perrigo (PRGO) Ireland $6.207B 10.65
Hill-Rom Holdings (HRC) United States $6.066B 15.05
Haemonetics (HAE) United States $5.406B 36.02
Envista Holdings (NVST) United States $4.393B 29.96
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.124B 0.00
ICU Medical (ICUI) United States $4.064B 31.01
Abcam (ABCZY) $3.897B 0.00
Neogen (NEOG) United States $3.787B 62.09
TG Therapeutics (TGTX) United States $3.474B 0.00
National Vision Holdings (EYE) United States $3.425B 532.38
GW Pharmaceuticals (GWPH) United Kingdom $3.013B 0.00
Agios Pharmaceuticals (AGIO) United States $2.686B 0.00
NuVasive (NUVA) United States $2.649B 36.91
DFB Healthcare Acquisitions (AHCO) United States $2.230B 0.00
Owens & Minor (OMI) United States $1.548B 34.67
Cardiovascular Systems (CSII) United States $1.541B 0.00
NanoString Technologies (NSTG) United States $1.393B 0.00
Aphria (APHA) Canada $1.351B 0.00
InMode (INMD) Israel $1.336B 33.71
MacroGenics (MGNX) United States $1.227B 0.00
Quanterix (QTRX) United States $1.162B 0.00
OraSure Technologies (OSUR) United States $1.057B 0.00
Cerus (CERS) United States $1.049B 0.00
BioLife Solutions (BLFS) United States $0.915B 476.33
Lantheus Holdings (LNTH) United States $0.869B 12.05
PetIQ (PETQ) United States $0.869B 24.92
Vapotherm (VAPO) United States $0.801B 0.00
Meridian Bioscience (VIVO) United States $0.785B 18.14
Phibro Animal Health (PAHC) United States $0.737B 16.86
LeMaitre Vascular (LMAT) United States $0.657B 40.11
Eagle Pharmaceuticals (EGRX) United States $0.646B 91.33
Omeros (OMER) United States $0.602B 0.00
Varex Imaging (VREX) United States $0.560B 24.29
Aurora Cannabis (ACB) Canada $0.560B 0.00
Surmodics (SRDX) United States $0.556B 60.99
Zynex (ZYXI) United States $0.494B 43.15
Viemed Healthcare (VMD) United States $0.377B 13.40
HEXO (HEXO) $0.364B 0.00
Cytosorbents (CTSO) United States $0.356B 0.00
Surface Oncology (SURF) United States $0.352B 0.00
Utah Medical Products (UTMD) United States $0.306B 26.25
InfuSystems Holdings (INFU) United States $0.268B 51.00
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Organigram Holdings (OGI) Canada $0.243B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.219B 0.00
Bovie Medical (APYX) United States $0.212B 0.00
Wound Management Technologies (SMTI) United States $0.191B 0.00
Exagen (XGN) United States $0.182B 0.00
Chimerix (CMRX) United States $0.170B 0.00
Female Health (VERU) United States $0.170B 0.00
Fonar (FONR) United States $0.138B 18.26
Liberty Health Sciences (LHSIF) United States $0.127B 0.00
Evolus (EOLS) United States $0.116B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
Capricor Therapeutics (CAPR) United States $0.090B 0.00
Rockwell Medical (RMTI) United States $0.070B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.069B 0.00
United-Guardian (UG) United States $0.068B 15.19
Brainsway (BWAY) Israel $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 11.86
Nephros (NEPH) United States $0.060B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.060B 0.00
MTech Acquisition (KERN) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.025B 0.00
FSD PHARMA INC (HUGE) Canada $0.024B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
Myomo (MYO) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00